bm 13505 has been researched along with 6-ketoprostaglandin f1 alpha in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Besse, T; Claeys, N; Gustin, T; Lambotte, L; Schroeyers, P | 1 |
| Bernheim, J; Green, J; Podjarny, E; Pomeranz, A; Rathaus, M | 1 |
| Cohen, DS; Dotson, R; Mathis, J; Olson, RW; Webb, RL | 1 |
3 other study(ies) available for bm 13505 and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Effect of PGI2 and thromboxane antagonist on liver ischemic injury.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Epoprostenol; Iloprost; Imidazoles; Ischemia; Liver; Male; Phenylacetates; Rats; Rats, Inbred Strains; Sulfonamides; Thromboxane B2 | 1989 |
Adriamycin-related hypertension in pregnant rats: response to a thromboxane receptor antagonist.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Disease Models, Animal; Doxorubicin; Female; Hypertension; Phenylacetates; Pregnancy; Pregnancy Complications, Cardiovascular; Rats; Rats, Wistar; Receptors, Thromboxane; Sulfonamides; Thromboxane B2; Thromboxanes | 1995 |
Beneficial effects of combined thromboxane synthase inhibition/receptor blockade with CGS 22652 in a canine model of coronary thrombosis.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Caprylates; Coronary Circulation; Coronary Thrombosis; Dinoprostone; Dogs; Hemodynamics; Indoles; Male; Myocardial Reperfusion; Phenylacetates; Platelet Activation; Platelet Aggregation Inhibitors; Pyridines; Receptors, Thromboxane; Streptokinase; Sulfonamides; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1993 |